AXE COMPUTE INC. (AGPU) company profile
Close on Nov 17, 2026Market cap $80.85MP/E –Yield –
About Axe Compute
Finance Services, SIC 6199
Axe Compute Inc. is an enterprise infrastructure and biomedical technology company operating through two main divisions: Compute Services and Treasury Management, and Drug Discovery Services. In its primary compute segment, the company provides on-demand access to high-performance GPU capacity for artificial intelligence, machine learning, and high-performance computing workloads through a decentralized network model, while actively managing a native token treasury. Its legacy drug discovery unit utilizes artificial intelligence, a biobank of tumor samples, and three-dimensional tissue models to support cancer drug development and evaluate potential therapeutics. The company serves enterprise clients, artificial intelligence developers, large-scale workload operators, and biopharmaceutical companies.
The company operates an asset-light compute network spanning over two hundred global locations, delivering access to more than 435,000 GPUs sourced primarily from third-party hardware suppliers. It also maintains a certified laboratory in Pittsburgh to conduct oncology testing and model development. The provided report does not state the location of the company's corporate headquarters.
Summary of the business section of Axe Compute's latest annual report, written by StockData.
Company profile
Company
- Legal name
- AXE COMPUTE INC.
- Founded
- 2002
- Headquarters
- Miami, FL
- Address
- 801 Brickell Avenue, Suite 510 33131
- Phone
- (305) 563-3850
- Website
- axecompute.com
- Employees
- 13, Dec 31, 2025
- Industry
- Finance Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, Pittsburgh, Pennsylvania
Stock & identifiers
- Ticker
- AGPU
- Former tickers
- POAI until Dec 12, 2025; AIPT until Aug 19, 2019; SKLN until Apr 2, 2018; BIOR until Aug 14, 2013
- Exchange
- Nasdaq
- IPO date
- May 3, 2010
- Shares outstanding
- 12M, Aug 13, 2026
- Public float
- $7.97M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-15 reverse, Sep 30, 2025; 1-for-20 reverse, Apr 24, 2023; 1-for-10 reverse, Oct 29, 2019; 1-for-25 reverse, Oct 28, 2016; 1-for-75 reverse, Oct 28, 2014
- SEC CIK
- 1446159
- CUSIP
- 74039M408
- ISIN
- US74039M4087
- FIGI
- BBG000PVXTF7
- Share class FIGI
- BBG001T619N6
- LEI
- 549300UQE748N2H9LE74
- EIN
- 33-1007393
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Christopher Miglino | CEO and Director | 1,800 |
| Raymond F. Vennare | Chief Executive Officer, Director | 19,677 |
| Joshua Blacher | Co-Chief Financial Officer | 15,856 |
| Jeremy Reese Yaukey-Witter | Co-Chief Financial Officer | 1,138 |
| Kyle Robert Okamoto | President | 244,389 |
| Thomas Louis McLaughlin | Chief Investment Officer | – |
| Charles Lee Nuzum Sr | Director | 23,541 |
| Thorsten Dirks | Director | 8,297 |
| Clair Gregory St. Sr | Director | 18,299 |
| Theodore Zhu | Director | 32,047 |
| Daniel E. Handley | Director | 13,284 |
| Matthew Hawryluk | Director | 14,176 |
| Shawn Matthews | Director | 1,166 |
| Veena Rao | Director | 9,177 |
| Nancy Chung-Welch | Director | 83,993 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2024 PEO1 | $525.00K | $525.00K | $423.27K | $4 | – |
| FY2024 PEO2 | $0 | $0 | $423.27K | $4 | – |
| FY2023 PEO1 | $525.00K | $525.00K | $425.30K | $17 | – |
| FY2023 PEO2 | $0 | $0 | $425.30K | $17 | – |
| FY2022 PEO1 | $121.63K | $121.63K | $511.87K | $32 | – |
| FY2022 PEO2 | $1.18M | $1.18M | $511.87K | $32 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2024
Summary compensation table from the latest proxy statement
| Executive | Salary | Other | Total | vs. prior year |
|---|---|---|---|---|
| Raymond F. Vennare | $525.00K | – | $525.00K | 0% |
| Josh Blacher | – | $453.94K | $453.94K | +167% |
| Pamela Bush | $51.25K | $341.34K | $392.59K | -3% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“We had 13 full-time employees and 1 part-time employee as of December 31, 2025.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?